Analysis of Radiation Dose and Estimation of Secondary Cancer Incidence in Organs Exposed to Radiotherapy in Breast Cancer

Background: Radiotherapy plays an important role in the treatment of breast cancer by reducing local recurrence and improving survival. However, the side effects of radiotherapy on other organs are unavoidable. Objectives: In this study, we aimed to analyze the radiation to organs that are exposed to radiation during breast radiotherapy and to assess the cancer incidence in these organs at risk (OARs). Methods: This study examined the data of dose-volume curves of 40 patients with breast cancer treated with three-dimensional conformal radiotherapy (3D-CRT) in Imam Hossein Hospital to investigate the risk of secondary malignancy for lungs and breast using biological formulas and the concept of organ-equivalent dose (OED) and excess absolute risk (EAR). Results: The findings showed that the average dose received by the contralateral breast and contralateral lung was 0.4 grays (Gy) and 0.67 Gy, respectively, in patients with the supraclavicular field, and 0.43Gy and 0.3Gy, respectively, in patients without the supraclavicular field. For these two organs, V5 was 0 and 0.09 percent, respectively. For the lungs on the treatment side, the average dose and V20 were 18.2 Gy and 34.12 percent with the supraclavicular field, and 11.39 Gy and 19.89 percent without it. For left breast cancer cases, the mean dose and V20 for the heart were 7.58 Gy and 11.57 percent with the supraclavicular field, and 5.85 Gy and 7.59 percent without it. The average received dose of thyroid and esophagus in patients treated with the supraclavicular field was 16.33 and 5.32 Gy, respectively. The EAR for contralateral breast, the same side lung, and contralateral lung was 7.46, 229, and 8.89, respectively. Conclusions: Development of a secondary malignancy after radiotherapy is a notable issue in patients with breast cancer, and there is a need to measure the probability of its occurrence. Accurate radiotherapy treatment planning can probably reduce its incidence.

Authors

Institutions

Publication Details

Journal
International Journal of Cancer Management
Published
2025-08-16
DOI
https://doi.org/10.5812/ijcm-161806
Primary Topic
Breast Cancer Treatment Studies
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Analysis of Radiation Dose and Estimation of Secondary Cancer Incidence in Organs Exposed to Radiotherapy in Breast Cancer

Ahmad Mostaar, Neda Hashemi, Ahmad R Mafi, Shaghayegh Kamian
1 links
International Journal of Cancer Management
Breast Cancer Treatment Studies
article

Analysis of Radiation Dose and Estimation of Secondary Cancer Incidence in Organs Exposed to Radiotherapy in Breast Cancer

Ahmad Mostaar, Neda Hashemi, Ahmad R Mafi, Shaghayegh Kamian
article en

Abstract

Background: Radiotherapy plays an important role in the treatment of breast cancer by reducing local recurrence and improving survival. However, the side effects of radiotherapy on other organs are unavoidable. Objectives: In this study, we aimed to analyze the radiation to organs that are exposed to radiation during breast radiotherapy and to assess the cancer incidence in these organs at risk (OARs). Methods: This study examined the data of dose-volume curves of 40 patients with breast cancer treated with three-dimensional conformal radiotherapy (3D-CRT) in Imam Hossein Hospital to investigate the risk of secondary malignancy for lungs and breast using biological formulas and the concept of organ-equivalent dose (OED) and excess absolute risk (EAR). Results: The findings showed that the average dose received by the contralateral breast and contralateral lung was 0.4 grays (Gy) and 0.67 Gy, respectively, in patients with the supraclavicular field, and 0.43Gy and 0.3Gy, respectively, in patients without the supraclavicular field. For these two organs, V5 was 0 and 0.09 percent, respectively. For the lungs on the treatment side, the average dose and V20 were 18.2 Gy and 34.12 percent with the supraclavicular field, and 11.39 Gy and 19.89 percent without it. For left breast cancer cases, the mean dose and V20 for the heart were 7.58 Gy and 11.57 percent with the supraclavicular field, and 5.85 Gy and 7.59 percent without it. The average received dose of thyroid and esophagus in patients treated with the supraclavicular field was 16.33 and 5.32 Gy, respectively. The EAR for contralateral breast, the same side lung, and contralateral lung was 7.46, 229, and 8.89, respectively. Conclusions: Development of a secondary malignancy after radiotherapy is a notable issue in patients with breast cancer, and there is a need to measure the probability of its occurrence. Accurate radiotherapy treatment planning can probably reduce its incidence.

International Journal of Cancer ManagementVol. 18(1)
Shahid Beheshti University of Medical Sciences (IR)
Openalex Percentile: Top 72%
Breast Cancer Treatment Studies
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.